These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32711158)

  • 21. Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease.
    Pucci S; Greggi C; Polidoro C; Piro MC; Celi M; Feola M; Gasbarra E; Iundusi R; Mastrangeli F; Novelli G; Orlandi A; Tarantino U
    J Transl Med; 2019 Apr; 17(1):118. PubMed ID: 30967152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory mechanisms and clinical manifestations of musculoskeletal aging.
    Grote C; Reinhardt D; Zhang M; Wang J
    J Orthop Res; 2019 Jul; 37(7):1475-1488. PubMed ID: 30919498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydroepiandrosterone and Bone.
    Zhou S; Glowacki J
    Vitam Horm; 2018; 108():251-271. PubMed ID: 30029729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine models of accelerated aging and musculoskeletal disease.
    Hambright WS; Niedernhofer LJ; Huard J; Robbins PD
    Bone; 2019 Aug; 125():122-127. PubMed ID: 30844492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.
    Yang YJ; Kim DJ
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Replacement therapy in adrenopause. Dehydroepiandrosterone and aging].
    Cramarossa L; Caruso AA
    Recenti Prog Med; 2001 Jan; 92(1):68-73. PubMed ID: 11260976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis and sarcopenia: the connections.
    Tarantino U; Baldi J; Celi M; Rao C; Liuni FM; Iundusi R; Gasbarra E
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S93-5. PubMed ID: 24046056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of mania precipitated by use of DHEA].
    Vacheron-Trystram MN; Cheref S; Gauillard J; Plas J
    Encephale; 2002; 28(6 Pt 1):563-6. PubMed ID: 12506269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adrenopause].
    Szkróbka W; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Jul; 25(145):77-82. PubMed ID: 18839621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.
    Straub RH; Konecna L; Hrach S; Rothe G; Kreutz M; Schölmerich J; Falk W; Lang B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2012-7. PubMed ID: 9626133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydroepiandrosterone Research: Past, Current, and Future.
    Klinge CM; Clark BJ; Prough RA
    Vitam Horm; 2018; 108():1-28. PubMed ID: 30029723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy?
    Villareal DT
    Treat Endocrinol; 2002; 1(6):349-57. PubMed ID: 15832488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia.
    Huang LT; Wang JH
    Front Med (Lausanne); 2021; 8():739251. PubMed ID: 34760899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disease-modifying effect of dehydroepiandrosterone in different stages of experimentally induced osteoarthritis: a histomorphometric study.
    Huang K; Bao JP; Jennings GJ; Wu LD
    BMC Musculoskelet Disord; 2015 Jul; 16():178. PubMed ID: 26228537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational musculoskeletal science: is sarcopenia the next clinical target after osteoporosis?
    Matthews GD; Huang CL; Sun L; Zaidi M
    Ann N Y Acad Sci; 2011 Nov; 1237():95-105. PubMed ID: 22082371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dehydroepiandrosterone (DHEA)--structure, clinical importance and the role in human body].
    Zdrojewicz Z; Ciszko B
    Postepy Hig Med Dosw; 2001; 55(6):835-54. PubMed ID: 11875781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dehydroepiandrosterone and Experimental Osteoarthritis.
    Huang K; Wu LD; Bao JP
    Vitam Horm; 2018; 108():367-384. PubMed ID: 30029735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly.
    Greco EA; Pietschmann P; Migliaccio S
    Front Endocrinol (Lausanne); 2019; 10():255. PubMed ID: 31068903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.
    Traish AM; Kang HP; Saad F; Guay AT
    J Sex Med; 2011 Nov; 8(11):2960-82; quiz 2983. PubMed ID: 22032408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.